Add-on Acquisition • Life Science

3SBio Acquires Sirton Pharmaceuticals

On January 26, 2015, 3SBio acquired life science company Sirton Pharmaceuticals

Acquisition Context
  • This is 3SBio’s 1st transaction in the Life Science sector.
  • This is 3SBio’s 1st transaction in Italy.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 26, 2015
Target Sirton Pharmaceuticals
Sector Life Science
Buyer(s) 3SBio
Deal Type Add-on Acquisition

Target Company

Sirton Pharmaceuticals

Villa Guardia, Italy
Sirton Pharmaceuticals SpA is a pharmaceutical contract manufacturing company located in Villa Guardia, near Cuomo, Italy. Sirton produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules, and pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

3SBio

Shenyang, China

Category Company
Founded 1993
Sector Life Science
Employees6,268
Revenue 9.1B CNY (2024)
DESCRIPTION

3SBio is a biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products. 3SBio was incorporated in 1993 and is based in Shenyang, China.


Deal Context for Buyer #
Overall 1 of 2
Sector: Life Science 1 of 2
Type: Add-on Acquisition 1 of 2
Country: Italy 1 of 1
Year: 2015 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-24 Zhejiang Wansheng Pharmaceutical Co.

Zhejiang, China

Zhejiang Wansheng Pharmaceutical Co., Ltd. is a pharmaceutical company.

Buy CN¥528M